Director of Neuro-Psychological Services & the Neurocognitive Assessment Program (NAP) Caron Treatment Centers
This session, led by Dr. Amber Deckard, will explore the critical role of neurocognitive assessment in the treatment of substance use disorders (SUDs). Dr. Deckard will discuss how advanced neurocognitive evaluation techniques can identify cognitive impairments associated with SUDs and inform personalized treatment strategies. The presentation will also highlight emerging neurorestorative care interventions designed to support brain recovery and improve patient outcomes, using real-world case examples to illustrate key concepts.
Learning Objectives:
Describe the importance and methodology of neurocognitive assessment in diagnosing and treating individuals with substance use disorders.
Identify current and emerging neurorestorative care approaches that can enhance cognitive recovery and support sustained recovery in SUD patients.
.jpg "Amber Deckard, PsyD photo")